CytomX Therapeutics to Announce Full-Year 2016 Financial Results

Go back to CytomX Therapeutics to Announce Full-Year 2016 Financial Results
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 2.75 -0.03 (1.08%)
Previous Close $2.78    52 Week High $24.68 
Open $2.75    52 Week Low $9.10 
Day High $2.78    P/E N/A 
Day Low $2.68    EPS $0.00 
Volume 3,081,415